VERTEX PHARMACEUTICALS

(VRTX)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 01-07-2022
287.32 USD   +1.96%
28/06INSIDER VERKOOP : Vertex Pharmaceuticals
MT
13/06VERTEX PHARMACEUTICALS : Een koopadvies van Cowen
MM
13/06VERTEX PHARMACEUTICALS : Argus ontvangt een koopadvies
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Nieuws in andere talen op VERTEX PHARMACEUTICALS
28/06INSIDER SELL : Vertex Pharmaceuticals
15/06TRANSCRIPT : Vertex Pharmaceuticals Incorporated Presents at Goldman Sachs 43rd Annual Glo..
13/06Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up ..
11/06Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up ..
10/06Vertex Pharmaceuticals to Present Scientific Abstracts on Cystic Fibrosis Drugs at Euro..
10/06Vertex to Present Data Demonstrating Significant Benefits of Long-Term and Early Treatm..
10/06Vertex to Present Data Demonstrating Significant Benefits of Long-Term and Early Treatm..
08/06†Vertex to Participate in the Goldman Sachs 43rd Annual Healthcare Conference on June 1..
08/06Vertex Pharmaceuticals Says US FDA Awards its Chronic Kidney Disease Treatment a Breakt..
08/06Vertex Announces Inaxaplin (VX-147) Granted Breakthrough Therapy Designation by U.S. FD..
08/06Vertex Pharmaceuticals Incorporated Announces Inaxaplin (VX-147) Granted Breakthrough T..
08/06Lupin Gets US FDA Tentative Approval for Ivacaftor Tablets
07/06Vertex présente de nouvelles données sur l'essai clinique de Phase 1 du VX-880 dans le ..
07/06Vertex präsentiert neue Daten aus der klinischen Phase-1/2-Studie zu VX-880 bei den 82...
06/06Vertex Pharma's Drug Candidate Improves Blood Glucose Control in Phase 1/2 Type 1 Diabe..
06/06Vertex Presents New Data from VX-880 Phase 1/2 Clinical Trial at the American Diabetes ..
02/06Vertex and CRISPR Therapeutics Announce Acceptance of Late-Breaking Abstract for CTX001..
31/05Vertex to Present New Data on VX-880 Clinical Trial at 82nd American Diabetes Associati..
31/05Vertex Pharmaceuticals Incorporated to Present New Data on VX-880 Clinical Trial
23/05Top Midday Gainers
23/05Catalyst Biosciences Stock Surges After Vertex Pharmaceuticals Buys Catalyst's Compleme..
23/05Catalyst Biosciences Shares Soar After Complement Portfolio Sale
23/05VERTEX PHARMACEUTICALS INC / MA : Other Events (form 8-K)
23/05Catalyst Biosciences Sells Complement Portfolio for $60 Million
23/05VERTEX PHARMACEUTICALS INCORPORATED : VRTX) acquired Complement Portfolio of Catalyst Bio..
19/05Vertex Pharmaceuticals - Suketu Upadhyay Elected to Vertex Board of Directors
18/05VERTEX PHARMACEUTICALS INC / MA : Submission of Matters to a Vote of Security Holders (for..
18/05Suketu Upadhyay Elected to Vertex Board of Directors
18/05Vertex Pharmaceuticals Incorporated Elects Suketu Upadhyay as Independent Director
17/05Vertex Pharmaceuticals Pledges $50 Million to Health Equity
17/05Vertex Announces Further Expansion in the Boston Seaport at Dedication of the Jeffrey L..
17/05Vertex Pharmaceuticals Incorporated Announces Further Expansion in the Boston Seaport A..
17/05Vertex Announces $50 Million Commitment to Health Equity With Three Initial Grants
06/05VERTEX PHARMACEUTICALS INC / MA Management's Discussion and Analysis of Financial Cond..
05/05Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q1 Revenue $2.1B, vs...
05/05Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q1 EPS $3.52, vs. Str..
05/05TRANSCRIPT : Vertex Pharmaceuticals Incorporated, Q1 2022 Earnings Call, May 05, 2022
05/05Vertex Pharmaceuticals Q1 Results Rise; Reaffirms 2022 Product Revenue Guidance
05/05VERTEX : Q1 Earnings Snapshot
05/05Vertex Reports First Quarter 2022 Financial Results
05/05Vertex Pharmaceuticals Incorporated Reiterates Earning Guidance for 2022
05/05Vertex Pharmaceuticals Incorporated Reports Earnings Results for the First Quarter Ende..
05/05EARNINGS REACTION HISTORY : Vertex Pharmaceuticals, 55.6% Follow-Through Indicator, 2.6% S..
02/05Vertex Pharmaceuticals Says FDA Places VX-880 Diabetes Study on Clinical Hold; Shares D..
02/05Vertex Provides Updates on Phase 1/2 Clinical Trial of VX-880 for the Treatment of Type..
02/05Vertex Pharmaceuticals Incorporated Provides Updates on Phase 1/2 Clinical Trial of Vx-..
02/05VERTEX PHARMA : FDA Puts VX-880 Diabetes Study on Hold
27/04Big Biotech Firms Have Several Catalysts Lined Up, UBS Says
21/04Vertex to Announce First Quarter 2022 Financial Results on May 5
21/04VRTX - Health Canada Grants Marketing Authorization for TRIKAFTA (elexacaftor/tezacafto..
21/04Vertex Pharmaceuticals Gets Canada's Approval of Trikafta for Children Aged Six to 11 Y..
20/04Health Canada Grants Marketing Authorization for TRIKAFTAģ (elexacaftor/tezacaftor/ivac..
20/04Vertex Pharmaceuticals Incorporated Announces Health Canada Grants Marketing Authorizat..
18/04INSIDER SELL : Vertex Pharmaceuticals
12/04INSIDER SELL : Vertex Pharmaceuticals
12/04INSIDER SELL : Vertex Pharmaceuticals
12/04INSIDER SELL : Vertex Pharmaceuticals
11/04INSIDER SELL : Vertex Pharmaceuticals
06/04INSIDER SELL : Vertex Pharmaceuticals
05/04INSIDER SELL : Vertex Pharmaceuticals
31/03Vertex Pharmaceuticals Says Treatment for Pain After Certain Surgeries Met Primary Endp..
31/03Vertex Announces Statistically Significant and Clinically Meaningful Results From Two P..
31/03Vertex Pharmaceuticals Incorporated Announces Statistically Significant and Clinically ..
31/03Vertex Pharmaceuticals to Advance VX-548 Pain Drug After Positive Phase 2 Studies
29/03American Kidney Fund Announces Support from Vertex Pharmaceuticals Inc. to Raise Awaren..
28/03Vertex Announces Reimbursement Agreement in Australia for TRIKAFTA for Patients With Cy..
26/03Vertex Announces Reimbursement Agreement in Australia for TRIKAFTAģ (elexacaftor/tezaca..
26/03Vertex Pharmaceuticals Incorporated Announces Reimbursement Agreement in Australia for ..
25/03Vertex Says Health Canada Gives Marketing Authorization to Expand Use of Kalydeco to Tr..
25/03Health Canada Grants Marketing Authorization for KALYDECOģ (ivacaftor) for Patients Wit..
22/03Vertex Pharmaceuticals Advances Kidney Disease Treatment Candidate Into Pivotal Clinica..
22/03Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated..
22/03Vertex Pharmaceuticals Incorporated Advances VX-147 into Pivotal Clinical Development f..
21/03INSIDER SELL : Vertex Pharmaceuticals
21/03INSIDER SELL : Vertex Pharmaceuticals
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op VERTEX PHARMACEUTICALS